Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 584

1.

Dissecting erm(41)-mediated macrolide inducible resistance in Mycobacterium abscessus.

Richard M, Gutiérrez AV, Kremer L.

Antimicrob Agents Chemother. 2019 Dec 2. pii: AAC.01879-19. doi: 10.1128/AAC.01879-19. [Epub ahead of print]

PMID:
31791943
2.

The clinical practice guideline palliative care for children and other strategies to enhance shared decision-making in pediatric palliative care; pediatricians' critical reflections.

Dreesens D, Veul L, Westermann J, Wijnands N, Kremer L, van der Weijden T, Verhagen E.

BMC Pediatr. 2019 Nov 29;19(1):467. doi: 10.1186/s12887-019-1849-0.

3.

Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study.

Leerink JM, Feijen ELAM, van der Pal HJH, Kok WEM, Mavinkurve-Groothuis AMC, Kapusta L, Pinto YM, Maas AHEM, Bellersen L, Teske AJ, Ronckers CM, Louwerens M, van Dalen EC, van Dulmen-den Broeder E, Batenburg L, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, van Leeuwen FE, de Vries ACH, Weijers G, de Korte CL, Loonen JJ, Neggers SJCMM, Versluys ABB, Tissing WJE, Kremer LCM; LATER Study Group.

Am Heart J. 2019 Nov 9;219:89-98. doi: 10.1016/j.ahj.2019.10.010. [Epub ahead of print]

4.

Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma.

Tas ML, Reedijk AMJ, Karim-Kos HE, Kremer LCM, van de Ven CP, Dierselhuis MP, van Eijkelenburg NKA, van Grotel M, Kraal KCJM, Peek AML, Coebergh JWW, Janssens GOR, de Keizer B, de Krijger RR, Pieters R, Tytgat GAM, van Noesel MM.

Eur J Cancer. 2019 Nov 11;124:47-55. doi: 10.1016/j.ejca.2019.09.025. [Epub ahead of print]

5.

The Dutch chaos case: A scoping review of knowledge and decision support tools available to clinicians in the Netherlands.

Dreesens D, Kremer L, van der Weijden T.

Health Policy. 2019 Dec;123(12):1288-1297. doi: 10.1016/j.healthpol.2019.10.001. Epub 2019 Oct 16.

PMID:
31722782
6.

Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study.

Clemens E, Broer L, Langer T, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Byrne J, Broeder EVD, Crocco M, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Kuehni CE, van der Pal H, Parfitt R, Deuster D, Matulat P, Spix C, Tillmanns A, Tissing WJE, Maier L, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE consortium.

Pharmacogenomics J. 2019 Oct 31. doi: 10.1038/s41397-019-0113-1. [Epub ahead of print]

PMID:
31666714
7.

Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls.

Catania A, Iuso A, Bouchereau J, Kremer LS, Paviolo M, Terrile C, Bénit P, Rasmusson AG, Schwarzmayr T, Tiranti V, Rustin P, Rak M, Prokisch H, Schiff M.

Orphanet J Rare Dis. 2019 Oct 29;14(1):236. doi: 10.1186/s13023-019-1185-3.

8.

Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Echaniz-Laguna A, Cuisset JM, Guyant-Marechal L, Aubourg P, Kremer L, Baaloul N, Verloes A, Beladgham K, Perrot J, Francou B, Latour P.

Neurogenetics. 2019 Oct 26. doi: 10.1007/s10048-019-00596-z. [Epub ahead of print]

PMID:
31655922
9.

Treatment-related mortality in children with cancer: Prevalence and risk factors.

Loeffen EAH, Knops RRG, Boerhof J, Feijen EAML, Merks JHM, Reedijk AMJ, Lieverst JA, Pieters R, Boezen HM, Kremer LCM, Tissing WJE.

Eur J Cancer. 2019 Nov;121:113-122. doi: 10.1016/j.ejca.2019.08.008. Epub 2019 Sep 27.

10.

A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3.

Dupont C, Chen Y, Xu Z, Roquet-Banères F, Blaise M, Witt AK, Dubar F, Biot C, Guérardel Y, Maurer FP, Chng SS, Kremer L.

J Biol Chem. 2019 Nov 15;294(46):17512-17523. doi: 10.1074/jbc.RA119.010135. Epub 2019 Sep 27.

PMID:
31562241
11.

Variedly connected 1,8-naphthalimide-7-chloroquinoline conjugates: Synthesis, anti-mycobacterial and cytotoxic evaluation.

Shalini, Johansen MD, Kremer L, Kumar V.

Bioorg Chem. 2019 Nov;92:103241. doi: 10.1016/j.bioorg.2019.103241. Epub 2019 Sep 4.

PMID:
31518758
12.

Mental Workload Relating Health Information System - A Literature Review.

Kremer L, Leeser L, Breil B.

Stud Health Technol Inform. 2019 Sep 3;267:289-296. doi: 10.3233/SHTI190840. Review.

PMID:
31483284
13.

Acceptance of mHealth Apps for Self-Management Among People with Hypertension.

Breil B, Kremer L, Hennemann S, Apolinário-Hagen J.

Stud Health Technol Inform. 2019 Sep 3;267:282-288. doi: 10.3233/SHTI190839.

PMID:
31483283
14.

Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß.

Kremer L, Hennes E, Brause A, Ursu A, Robke L, Matsubayashi HT, Nihongaki Y, Flegel J, Mejdrová I, Eickhoff J, Baumann M, Nencka R, Janning P, Kordes S, Schöler HR, Sterneckert J, Inoue T, Ziegler S, Waldmann H.

Angew Chem Int Ed Engl. 2019 Nov 11;58(46):16617-16628. doi: 10.1002/anie.201907632. Epub 2019 Oct 4. Review.

PMID:
31454140
15.

Relating Factors for Acceptance of Health Care Technology: Focus on Mental Workload.

Kremer L, Sen S, Breil B.

Stud Health Technol Inform. 2019 Aug 21;264:1953-1954. doi: 10.3233/SHTI190730.

PMID:
31438424
16.

Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group.

Michel G, Mulder RL, van der Pal HJH, Skinner R, Bárdi E, Brown MC, Vetsch J, Frey E, Windsor R, Kremer LCM, Levitt G.

J Cancer Surviv. 2019 Oct;13(5):759-772. doi: 10.1007/s11764-019-00795-5. Epub 2019 Aug 8. Review.

PMID:
31396878
17.

The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.

Gutiérrez AV, Richard M, Roquet-Banères F, Viljoen A, Kremer L.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01000-19. doi: 10.1128/AAC.01000-19. Print 2019 Oct.

PMID:
31332077
18.

1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis.

Korycka-Machała M, Viljoen A, Pawełczyk J, Borówka P, Dziadek B, Gobis K, Brzostek A, Kawka M, Blaise M, Strapagiel D, Kremer L, Dziadek J.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00441-19. doi: 10.1128/AAC.00441-19. Print 2019 Oct.

PMID:
31332069
19.

Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.

Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, van Dulmen-den Broeder E, Visser O, Maduro JH, van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group.

Cancer Causes Control. 2019 Sep;30(9):909-922. doi: 10.1007/s10552-019-01204-z. Epub 2019 Jul 12.

PMID:
31300947
20.

Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessus.

Madani A, Ridenour JN, Martin BP, Paudel RR, Abdul Basir A, Le Moigne V, Herrmann JL, Audebert S, Camoin L, Kremer L, Spilling CD, Canaan S, Cavalier JF.

ACS Infect Dis. 2019 Sep 13;5(9):1597-1608. doi: 10.1021/acsinfecdis.9b00172. Epub 2019 Jul 25.

PMID:
31299146
21.

Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.

Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, de Vathaire F, Reulen RC.

Eur J Cancer. 2019 Aug;117:71-83. doi: 10.1016/j.ejca.2019.05.013. Epub 2019 Jun 28.

PMID:
31260818
22.

Crystal structure of the aminoglycosides N-acetyltransferase Eis2 from Mycobacterium abscessus.

Ung KL, Alsarraf HMAB, Olieric V, Kremer L, Blaise M.

FEBS J. 2019 Nov;286(21):4342-4355. doi: 10.1111/febs.14975. Epub 2019 Jul 12.

PMID:
31254444
23.

Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.

Santucci P, Johansen MD, Point V, Poncin I, Viljoen A, Cavalier JF, Kremer L, Canaan S.

Sci Rep. 2019 Jun 17;9(1):8667. doi: 10.1038/s41598-019-45164-5.

24.

Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.

Viljoen A, Raynaud C, Johansen MD, Roquet-Banères F, Herrmann JL, Daher W, Kremer L.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00705-19. doi: 10.1128/AAC.00705-19. Print 2019 Sep.

PMID:
31209005
25.

Systematic review of mydriatics used for screening of retinopathy in premature infants.

Kremer LJ, Reith DM, Medlicott N, Broadbent R.

BMJ Paediatr Open. 2019 May 9;3(1):e000448. doi: 10.1136/bmjpo-2019-000448. eCollection 2019.

26.

Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry.

Perez-Zsolt D, Erkizia I, Pino M, García-Gallo M, Martin MT, Benet S, Chojnacki J, Fernández-Figueras MT, Guerrero D, Urrea V, Muñiz-Trabudua X, Kremer L, Martinez-Picado J, Izquierdo-Useros N.

Nat Microbiol. 2019 Sep;4(9):1558-1570. doi: 10.1038/s41564-019-0453-2. Epub 2019 Jun 3.

PMID:
31160823
27.

Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.

Vila-Caballer M, González-Granado JM, Zorita V, Abu Nabah YN, Silvestre-Roig C, Del Monte-Monge A, Molina-Sánchez P, Ait-Oufella H, Andrés-Manzano MJ, Sanz MJ, Weber C, Kremer L, Gutiérrez J, Mallat Z, Andrés V.

J Mol Cell Cardiol. 2019 Jul;132:154-163. doi: 10.1016/j.yjmcc.2019.05.009. Epub 2019 May 21.

PMID:
31121182
28.

The diagnosis of inborn errors of metabolism by an integrative "multi-omics" approach: A perspective encompassing genomics, transcriptomics, and proteomics.

Stenton SL, Kremer LS, Kopajtich R, Ludwig C, Prokisch H.

J Inherit Metab Dis. 2019 May 22. doi: 10.1002/jimd.12130. [Epub ahead of print] Review.

PMID:
31119744
29.

A conceptual framework for patient-directed knowledge tools to support patient-centred care: Results from an evidence-informed consensus meeting.

Dreesens D, Stiggelbout A, Agoritsas T, Elwyn G, Flottorp S, Grimshaw J, Kremer L, Santesso N, Stacey D, Treweek S, Armstrong M, Gagliardi A, Hill S, Légaré F, Ryan R, Vandvik P, van der Weijden T.

Patient Educ Couns. 2019 Oct;102(10):1898-1904. doi: 10.1016/j.pec.2019.05.003. Epub 2019 May 4.

PMID:
31118137
30.

Lsr2 Is an Important Determinant of Intracellular Growth and Virulence in Mycobacterium abscessus.

Le Moigne V, Bernut A, Cortès M, Viljoen A, Dupont C, Pawlik A, Gaillard JL, Misguich F, Crémazy F, Kremer L, Herrmann JL.

Front Microbiol. 2019 Apr 30;10:905. doi: 10.3389/fmicb.2019.00905. eCollection 2019.

31.

CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.

Bárcena C, Aran G, Perea L, Sanjurjo L, Téllez É, Oncins A, Masnou H, Serra I, García-Gallo M, Kremer L, Sala M, Armengol C, Sancho-Bru P, Sarrias MR.

EBioMedicine. 2019 May;43:513-524. doi: 10.1016/j.ebiom.2019.04.052. Epub 2019 May 8.

32.

Miller Fisher syndrome mimicking botulism: Clinical and pathophysiological discussion of a case.

Bigaut K, Kremer L, Hacquard A, Collongues N, De Seze J.

Rev Neurol (Paris). 2019 Jun;175(6):403-405. doi: 10.1016/j.neurol.2018.06.012. Epub 2019 Apr 30. No abstract available.

PMID:
31047688
33.

Dissecting the membrane lipid binding properties and lipase activity of Mycobacterium tuberculosis LipY domains.

Santucci P, Smichi N, Diomandé S, Poncin I, Point V, Gaussier H, Cavalier JF, Kremer L, Canaan S.

FEBS J. 2019 Aug;286(16):3164-3181. doi: 10.1111/febs.14864. Epub 2019 May 16.

PMID:
31034693
34.

The involvement of primary care physicians in care for childhood cancer survivors.

Streefkerk N, Heins MJ, Teepen JC, Feijen EAM, Bresters D, van Dulmen-den Broeder E, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, van Leeuwen FE, Loonen JJ, van der Pal HJH, Ronckers CM, Versluys AB, Tissing WJE, Korevaar JC, Kremer LCM; DCOG-LATER Study Group.

Pediatr Blood Cancer. 2019 Aug;66(8):e27774. doi: 10.1002/pbc.27774. Epub 2019 Apr 29.

PMID:
31033160
35.

Detection of Mycobacterium tuberculosis in paucibacillary sputum: performances of the Xpert MTB/RIF ultra compared to the Xpert MTB/RIF, and IS6110 PCR.

Kolia-Diafouka P, Carrère-Kremer S, Lounnas M, Bourdin A, Kremer L, Van de Perre P, Godreuil S, Tuaillon E.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):365-370. doi: 10.1016/j.diagmicrobio.2019.02.008. Epub 2019 Feb 21.

PMID:
31005403
36.

Colorectal Cancer Screening in Childhood Cancer Survivors.

Teepen JC, Ronckers CM, Kremer LCM.

J Natl Cancer Inst. 2019 Nov 1;111(11):1114-1115. doi: 10.1093/jnci/djz063. No abstract available.

PMID:
30980664
37.

A case of acute posterior multifocal placoid pigment epitheliopathy with aseptic meningitis and cerebral infarction.

Bigaut K, Kremer L, Hacquard A, Wolff B, Collongues N, De Seze J.

Rev Neurol (Paris). 2019 May;175(5):329-331. doi: 10.1016/j.neurol.2018.06.011. Epub 2019 Mar 28. No abstract available.

PMID:
30928157
38.

Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Jaspers MMW, van Santen HM, van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM; DCOG-LATER Study Group.

JAMA Oncol. 2019 May 1;5(5):671-680. doi: 10.1001/jamaoncol.2018.6862.

PMID:
30920605
39.

Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study.

Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, de Vries A, Kuehni CE, Garrè ML, Kepak T, Kruseova J, Winther JF, Kremer LC, van Dulmen-den Broeder E, Tissing WJ, Rechnitzer C, Kenborg L, Hasle H, Grabow D, Parfitt R, Binder H, Carleton BC, Byrne J, Kaatsch P, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM.

JMIR Res Protoc. 2019 Mar 19;8(3):e11868. doi: 10.2196/11868.

40.

Improving Clinical Outcomes and Quality of Life with Massage Therapy in Youth and Young Adults with Cystic Fibrosis: a Pilot Study.

Zink KK, Chini B, Cowens J, Kremer L, Lin L.

Int J Ther Massage Bodywork. 2019 Mar 4;12(1):4-15. eCollection 2019 Mar.

41.

Reducing pain in children with cancer: Methodology for the development of a clinical practice guideline.

Loeffen EAH, Kremer LCM, van de Wetering MD, Mulder RL, Font-Gonzalez A, Dupuis LL, Campbell F, Tissing WJE; Pain in Children with Cancer Guideline Development Panel.

Pediatr Blood Cancer. 2019 Jun;66(6):e27698. doi: 10.1002/pbc.27698. Epub 2019 Mar 7.

PMID:
30848078
42.

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.

Kremer L, Taleb O, Boehm N, Mensah-Nyagan AG, Trifilieff E, de Seze J, Brun S.

J Neuroinflammation. 2019 Mar 2;16(1):54. doi: 10.1186/s12974-019-1441-4.

43.

Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study.

Teepen JC, Kok JL, Kremer LC, Tissing WJE, van den Heuvel-Eibrink MM, Loonen JJ, Bresters D, van der Pal HJ, Versluys B, van Dulmen-den Broeder E, Nijsten T, Hauptmann M, Hollema N, Dolsma WV, van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group.

J Natl Cancer Inst. 2019 Feb 25. doi: 10.1093/jnci/djy212. [Epub ahead of print]

PMID:
30802904
44.

Design, synthesis, anti-mycobacterial and cytotoxic evaluation of C-4 functionalized 1,8-naphthalimide-heterocyclic hydrazide conjugates.

Shalini, Johansen MD, Kremer L, Kumar V.

Chem Biol Drug Des. 2019 Jul;94(1):1300-1305. doi: 10.1111/cbdd.13503. Epub 2019 Mar 7.

PMID:
30776195
45.

CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses.

Bernut A, Dupont C, Ogryzko NV, Neyret A, Herrmann JL, Floto RA, Renshaw SA, Kremer L.

Cell Rep. 2019 Feb 12;26(7):1828-1840.e4. doi: 10.1016/j.celrep.2019.01.071.

46.

Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.

Feijen EAM, Leisenring WM, Stratton KL, Ness KK, van der Pal HJH, van Dalen EC, Armstrong GT, Aune GJ, Green DM, Hudson MM, Loonen J, Oeffinger KC, Robison LL, Yasui Y, Kremer LCM, Chow EJ.

JAMA Oncol. 2019 Jun 1;5(6):864-871. doi: 10.1001/jamaoncol.2018.6634.

PMID:
30703192
47.

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).

Bigaut K, Achard S, Hemmert C, Baloglu S, Kremer L, Collongues N, De Sèze J, Kremer S.

PLoS One. 2019 Jan 29;14(1):e0211465. doi: 10.1371/journal.pone.0211465. eCollection 2019.

48.

Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors.

van de Loo LEXM, van den Berg MH, Overbeek A, van Dijk M, Damen L, Lambalk CB, Ronckers CM, van den Heuvel-Eibrink MM, Kremer LCM, van der Pal HJ, Laven JSE, Tissing WJE, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO Study Group.

Fertil Steril. 2019 Feb;111(2):372-380. doi: 10.1016/j.fertnstert.2018.10.016.

PMID:
30691634
49.

Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients.

Constine LS, Ronckers CM, Hua CH, Olch A, Kremer LCM, Jackson A, Bentzen SM.

Clin Oncol (R Coll Radiol). 2019 Mar;31(3):199-207. doi: 10.1016/j.clon.2019.01.002. Epub 2019 Jan 19.

PMID:
30670336
50.

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Constine LS, Bass JK, Kuehni CE, Langer T, van Dalen EC, Bardi E, Bonne NX, Brock PR, Brooks B, Carleton B, Caron E, Chang KW, Johnston K, Knight K, Nathan PC, Orgel E, Prasad PK, Rottenberg J, Scheinemann K, de Vries ACH, Walwyn T, Weiss A, Am Zehnhoff-Dinnesen A, Cohn RJ, Landier W; International Guideline Harmonization Group ototoxicity group.

Lancet Oncol. 2019 Jan;20(1):e29-e41. doi: 10.1016/S1470-2045(18)30858-1. Review.

PMID:
30614474

Supplemental Content

Loading ...
Support Center